Erratum: Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment

Bertrand Joseph; Philippe Marchetti; Pierre Formstecher; Guido Guido Kroemer; Rolf Lewensohn; Boris Zhivotovsky

doi:10.1038/onc.2017.78

Back

Erratum: Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment

Corrigendum 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment

Bertrand Joseph, Philippe Marchetti, Pierre Formstecher, Guido Guido Kroemer, Rolf Lewensohn, Boris Zhivotovsky

Article2002

Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment

Bertrand Joseph, Philippe Marchetti, Pierre Formstecher, Guido Guido Kroemer, Rolf Lewensohn, Boris Zhivotovsky

Article2004

Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas

Miguel-Angel Gallego, Bertrand Joseph, Therese H Hemström, Susan Tamiji, Laurent Mortier, Guido Guido Kroemer, Pierre Formstecher, Boris Zhivotovsky, Philippe Marchetti

Article2017

Gefitinib: an “orphan” drug for non-small cell lung cancer

Dimitrios C. Ziogas, Michalis Liontos, Anastasios Kyriazoglou, Georgios Tsironis, Aristotelis Bamias, Meletios A Dimopoulos

Article1997

Second line treatment of non-small cell lung cancer with paclitaxel and gemcitabine

Stylianos Kakolyris, C. Kourousis, N. Androulakis, Meletios A Dimopoulos, E. Papadakis, S. Tzannes, Thanos Kotsakis, N. Vardakis, N. Merambeliotakis, C. Kalbakis, D. Xatzidaki, V. Georgoulias